Home » Topics » BioWorld Science

BioWorld Science
RSS

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Sugen reports antihyperproliferative agents

Dec. 10, 1996

Merck & Co. reveals new agents for BPH

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996

Medarex bispecific antibody enters phase II in colon cancer patients

Dec. 9, 1996

MGI Pharma acquires drugs from Ilex Oncology

Dec. 9, 1996

Another British Biotech compound reaches clinical stage

Dec. 9, 1996

Successful phase III results reported for British Biotech PAF antagonist

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...